Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. NovoCure Ltd shares valued at $231,800 were purchased by Brackmann Christoph on Jul 29 ’25. At $11.59 per share, Brackmann Christoph acquired 20,000 shares. The insider’s holdings grew to 141,150 shares worth approximately $1.7 million following the completion of this transaction.
Also, Stafford Kristin sold 999 shares, netting a total of over 17,259 in proceeds. Following the sale of shares at $17.28 each, the insider now holds 3,054 shares.
Before that, LEUNG GABRIEL had sold 999 shares from its account. In a trade valued at $17,297, the Director traded NovoCure Ltd shares for $17.31 each. Upon closing the transaction, the insider’s holdings decreased to 999 shares, worth approximately $0.98 million.
As published in a research note from Wells Fargo on July 25, 2025, NovoCure Ltd [NVCR] has been rated down from an Overweight to an Equal weight and the price target has been revised to $14.50. Analysts at Ladenburg Thalmann started covering the stock with ‘”a Buy”‘ outlook in a report released in early July. As of December 02, 2024, Evercore ISI has increased its “an In-line” rating to a “an Outperform” for NVCR. Earlier on October 16, 2024, H.C. Wainwright upgraded its rating. Their new recommendation was “a Buy” for NVCR stock which previously was a “a Neutral”.
Analyzing NVCR Stock Performance
On last trading session, NovoCure Ltd [NASDAQ: NVCR] rose 0.97% to $12.02. The stock’s lowest price that day was $11.8, but it reached a high of $12.12 in the same session. During the last five days, there has been a surge of approximately 0.97%. Over the course of the year, NovoCure Ltd shares have dropped approximately -33.75%. Shares of the company reached a 52-week high of $31.17 on 01/02/25 and a 52-week low of $10.87 on 08/11/25.
Support And Resistance Levels for NovoCure Ltd (NVCR)
According to the 24-hour chart, there is a support level at 11.84, which, if violated, would cause prices to drop to 11.66. In the upper region, resistance lies at 12.16. The next price resistance is at 12.30. RSI (Relative Strength Index) is 43.89 on the 14-day chart, showing neutral technical sentiment.
Is NovoCure Ltd subject to short interest?
Stocks of NovoCure Ltd saw a sharp rise in short interest on 2025-08-15 jumping by 0.58 million shares to 5.51 million. Data from Yahoo Finance shows that the short interest on 2025-07-15 was 4.93 million shares. A jump of 10.57% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.68 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.68.
Which companies own the most shares of NovoCure Ltd (NVCR)?
In terms of NovoCure Ltd share price expectations, FactSet research, analysts set an average price target of 14.5 in the next 12 months, up nearly 21.75% from the previous closing price of $11.91. Analysts anticipate NovoCure Ltd stock to reach 14.5 by 2025, with the lowest price target being 14.5. In spite of this, 5 analysts ranked NovoCure Ltd stock as Hold at the end of 2025. On November 20, 2023, JP Morgan assigned a price target of “a Neutral” to the stock and resumed coverage with a $15.
